AG
NVS icon

Ascent Group’s Novartis NVS Stock Holding History

Ascent Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.03M Buy
13,293
+173
+1% +$26.5K 0.07% 250
2025
Q4 		$1.81M Sell
13,120
-5
-0% -$655 0.06% 261
2025
Q3 		$1.68M Sell
13,125
-996
-7% -$122K 0.06% 271
2025
Q2 		$1.71M Buy
14,121
+97
+0.7% +$10.9K 0.07% 239
2025
Q1 		$1.56M Buy
14,024
+7,176
+105% +$764K 0.07% 263
2024
Q4 		$666K Buy
6,848
+157
+2% +$16.7K 0.05% 330
2024
Q3 		$770K Buy
6,691
+275
+4% +$31.2K 0.06% 318
2024
Q2 		$683K Buy
6,416
+345
+6% +$34.6K 0.06% 316
2024
Q1 		$587K Sell
6,071
-189
-3% -$19.4K 0.05% 328
2023
Q4 		$629K Sell
6,260
-289
-4% -$27.9K 0.06% 308
2023
Q3 		$611K Sell
6,549
-582
-8% -$59.1K 0.07% 291
2023
Q2 		$735K Sell
7,131
-98
-1% -$9.8K 0.08% 268
2023
Q1 		$665K Sell
7,229
-29
-0.4% -$2.53K 0.07% 275
2022
Q4 		$658K Buy
7,258
+48
+0.7% +$4.04K 0.08% 268
2022
Q3 		$585K Buy
7,210
+597
+9% +$49.5K 0.07% 268
2022
Q2 		$568K Buy
6,613
+407
+7% +$35.7K 0.07% 281
2022
Q1 		$545K Buy
6,206
+2,999
+94% +$260K 0.06% 285
2021
Q4 		$279K Buy
+3,207
New +$266K 0.04% 387

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ascent Group's NVS Position: Q1 2026 in Review

Ascent Group increased its Novartis (NVS) stake by 1.3% in Q1 2026, buying an estimated $26.5K and bringing the position to 13,293 shares worth $2.03M. The position accounts for 0.07% of the portfolio, ranked #250.

Ascent Group first reported a position in NVS in Q4 2021 and has held it in 18 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Ascent Group held 13,293 shares of Novartis worth $2.03M as of Q1 2026.
  • Ascent Group bought 173 Novartis shares in Q1 2026, an estimated $26.5K.
  • Novartis made up 0.07% of Ascent Group's portfolio in Q1 2026, its #250 holding.
  • Ascent Group first reported a position in Novartis in Q4 2021 and has held it in 18 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.